2008

• Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008 Jan 1;112(1):17-26.
• Chen JH, Agrawal G, Carpenter P, Mehta RS, Nalcioglu O, Su MY. Pathological Axillary Lymph Node Status in HER-2 Receptor Positive and Negative Breast Cancers. Ann Surg Oncol. 2008 Mar;15(3):941-2
• Baek HM, Chen JH, Yu HJ, Mehta RS, Nalcioglu O, Su MY. Detection of Choline Signal in Human Breast Lesions with Chemical-Shift Imaging. In Press, J. Mag. Reson. Imag. 2008.
• Chen JH, Baek HM, Nalcioglu O, Su MY. Estrogen Receptor and Breast MR Imaging Features: A Correlation Study. In Press, J. Mag. Reson. Imag. 2008.
• Baek HM, Chen JH, Nalcioglu O, Su MY. Choline as a Biomarker for Cell Proliferation: Do the Results from Proton MR Spectroscopy Show Difference between HER2/neu Positive and Negative Breast Cancers? In Press, International Journal of Cancer, 2008.
• Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can Dynamic Contrast-Enhanced MRI (DCE-MRI) Predict Tumor Recurrence and Lymph Node Status in Patients with Breast Cancer? In Press, Ann Oncol. 2008.
• Baek HM, Chen JH, Nalcioglu O, Su MY. Proton MR Spectroscopy for Monitoring Early Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy. In Press, Annals of Oncology, 2008.
• Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. MR Imaging Features of Fibrocystic Change of the Breast. In Press, Magn Reson Imaging 2008.
• Chen JH, Nalcioglu O, Su MY. MR Imaging Features of Breast Cancer Correlated with Hormonal Receptors: Does Progesterone Receptor Matter? In Press, Annals of Oncology, 2008.
• Chen JH, Nalcioglu O, Su MY. Fibrocystic Change of the Breast Presenting as a Focal Lesion Mimicking Breast Cancer in MR Imaging. In Press, J. Mag. Reson. Imag. 2008.
• John Serences, Sameer Saproo, Miranda Scolari, Tiffany Ho, L. Tugan Muftuler “Estimating the influence of attention on population codes in human visual cortex”. Submitted to Journal of Neuroscience.
• Jeffrey D. Johnson, L. Tugan Muftuler, and Michael D. Rugg. “Multiple repetitions reveal functionally-and anatomically-distinct patterns of hippocampal activity during continuous recognition memory”. Submitted to Hippocampus.
• Mehmet Burcin Unlu and Gultekin Gulsen, “Effects of the Time Variation of Bioluminescent Source on the Tomographic Reconstruction”, Applied Optics, Vol. 47, 799-806, (2008).
• Mehmet Burcin Unlu, Ozlem Birgul, Roshanak Shafiiha, and Gultekin Gulsen, “A Simulation Study of the Variability of Indocyanine Green Kinetics and Using Structural a priori Information in Dynamic Contrast Enhanced Diffuse Optical Tomography (DCE-DOT)”, in press, PMB, 2008.

2007

• Nishi RA, Liu H, Chu Y, Hamamura M, Su MY, Nalcioglu O, Anderson AJ. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma. 2007 Apr;24(4):674-689.
• Chen JH, Agrawal G, Feig B, Baek H-M, Carpenter PM, Nalcioglu O, Su MY. Triple Negative Breast Cancer: MR Imaging Features in 29 Patients. Ann Oncol. 2007 Dec;18(12):2042-3.
• Baek HM, Yu H, Chen JH, Nalcioglu O, Su MY. Quantitative Correlation between 1H MR Spectroscopy and Dynamic Contrast-Enhanced MRI of Human Breast Cancer. Magn Reson Imaging. 2007 Dec 3; [Epub ahead of print]
• Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. MRI in Predicting Pathological Response of Triple Negative Breast Cancer Following Neoadjuvant Chemotherapy. Clin Oncol. 2007 Dec 10;25(35):5667-9.
• Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol. 2007; 25(18):2618-2620.
• Yu H, Chen JH, Su MY, Mehta R, Nalcioglu O, Su MY. MRI Measurements of Tumor Size and Pharmacokinetic Parameters as Early Predictor of Response in Breast Cancer Patients Undergoing Neoadjuvant AC-Chemotherapy. J. Mag. Reson. Imag. 2007 Sep; 26(3):615-623.
• Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg. 2007 Sep;142(9):855-61.
• Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg. 2007 Oct;73(10):977-80.
• Agrawal G, Chen JH, Baek HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY. MRI features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol. 2007 Nov;18(11):1903-4.
• Gang Chen, L Tugan Muftuler, Seung H Ha and Orhan Nalcioglu “An optimization method for designing SENSE imaging RF coil arrays”, Journal of Magnetic Resonance, 186: 273-281 (2007).
• Kent L Nastiuk, Hui Liu, Mark Hamamura, L. Tugan Muftuler, Orhan Nalcioglu, John J. Krolewski “In vivo MRI volumetric measurement of prostate regression and growth in mice” BMC Urology 2007, 7:12 (2007).

2006

• Tapp PD, Head K, Head E, Milgram NW, Muggenburg BA, Su MY. Application of an automated voxel-based morphometry technique to assess regional gray and white matter brain atrophy in a canine model of aging. Neuroimage. 2006 Jan 1;29(1):234-44.
• Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA. 2006; May;19(2):96-104.
• Chu Y, Su MY, Mandelkern M, Nalcioglu O. Resolution Improvement in Positron Emission Tomography Using Anatomical Magnetic Resonance Imaging. Technol Cancer Res Treat. 2006; Aug:5(4):311-318.
• Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Comparison of Choline and Pharmacokinetic Parameters in Breast Cancer Measured by MR Spectroscopic Imaging and Dynamic Contrast Enhanced MRI Technol Cancer Res Treat. 2006; Aug:5(4):401-410.
• Chen YF, Wang H, Chu Y, Huang YC, Su MY. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 22(2):177-184.
• Wang H, Su MY. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment. Dement Geriatr Cogn Disord. 2006; 22(3):223-229.
• Wang H, Golob EJ, Su MY. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006; 24(3):695-700.
• Ray K, Wang H, Chu Y, Chen YF, Bert A, Hasso A, Su MY. Apparent Diffusion Coefficient in Regional Gray Matter and White Matter Structures Involved in Mild Cognitive Impairment. Radiology 2006; 241:197-205.
• Mark Hamamura, L. Tugan Muftuler, Ozlem Birgul, Orhan Nalcioglu “Measurement of ion diffusion using magnetic resonance electrical impedance tomography”, Phys Med Biol. 51(11):2753-62 (2006)
• L. Tugan Muftuler, Mark Hamamura, Ozlem Birgul, Orhan Nalcioglu, “In Vivo MRI Electrical Impedance Tomography (MREIT) of Tumors”, Technology in Cancer Research and Treatment v 5: 381-387 August (2006)
• L. Tugan Muftuler, Gang Chen, Orhan Nalcioglu, "Design of an RF Coil Array Optimized for SENSE Imaging Using Target Field Method", Physics in Medicine and Biology 51: 6457-6469 (2006).
• Ozlem Birgul, Mark Hamamura, L. Tugan Muftuler, Orhan Nalcioglu “Contrast and spatial resolution in MREIT using low amplitude current”, Physics in Medicine and Biology 51: 5035-5049 (2006).
• M. B. Unlu, O. Birgul, R. Shafiiha, G. Gulsen and O. Nalcioglu, “Diffuse Optical Tomographic Reconstruction Using Multi-frequency Data”, Journal of Biomedical Optics, Vol. 11, (2006).
• G. Gulsen, O. Birgul, M. B. Unlu, R. Shafiiha and Nalcioglu O. “A Multi-modality system for animal imaging: hybrid MR-DOT system”, J. Tech. Cancer Research & Treatment 5 (4): 351-363 (2006).